Drug Shortage Report for SANDOZ ESTRADIOL DERM 75
Report ID | 182553 |
Drug Identification Number | 02246968 |
Brand name | SANDOZ ESTRADIOL DERM 75 |
Common or Proper name | ESTRADIOL |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | ESTRADIOL |
Strength(s) | 75MCG |
Dosage form(s) | PATCH |
Route of administration | TRANSDERMAL TRANSDERMAL |
Packaging size | 8TTS |
ATC code | G03CA |
ATC description | ESTROGENS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-01-25 |
Estimated end date | 2023-03-10 |
Actual end date | 2023-02-17 |
Shortage status | Resolved |
Updated date | 2023-03-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-03-02 | French | Compare |
v5 | 2023-03-02 | English | Compare |
v4 | 2023-02-09 | French | Compare |
v3 | 2023-02-09 | English | Compare |
v2 | 2023-01-27 | French | Compare |
v1 | 2023-01-27 | English | Compare |
Showing 1 to 6 of 6